1. Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022
- Author
-
Christian Rothermundt, Dimosthenis Andreou, Jean-Yves Blay, Thomas Brodowicz, Ingrid M.E. Desar, Palma Dileo, Hans Gelderblom, Rick Haas, Jens Jakob, Robin L. Jones, Ian Judson, Wolfgang G. Kunz, Berndadette Liegl-Atzwanger, Lars H. Lindner, Christina Messiou, Aisha B. Miah, Peter Reichardt, Joanna Szkandera, Winette T.A. van der Graaf, Winan J. van Houdt, Eva Wardelmann, Silvia Hofer, Thomas Barth, Sebastian Bauer, Veronika Blum, Beata Bode, Sylvie Bonvalot, Judith Bovee, Petra Braam, Jean Martin Broto, Angelo Dei Tos, Dominik Denschlag, Ingrid Desar, Antonia Digklia, Uta Dirksen, Thomas Douchy, Florence Duffaud, Mikael Eriksson, Stefan Fröhling, Alessandro Gronchi, Jenrik Hardes, Wolfgang Hartmann, Peter Hohenberger, Daphne Hompes, Paul Huang, Antoine Italiano, Robin Jones, Günter Köhler, Attila Kollàr, Fatime Krasniqi, Stijn Krol, Wolfgang Kunz, Franel Le Grange, Cécile Le Pechoux, Alexandre LeCesne, Andreas Leithner, Bernadette Liegl-Atzwanger, Lars Lindner, Gunhild Mechtersheimer, Aisha Miah, Daniel Pink, Cleo Romagosa, Piotr Rutkowski, Akmel Safwat, Claudia Sangalli, Khin Thway, Per-Ulf Tunn, Winette Van der Graaf, Winan Van Houdt, Ralph Zachariah, Sander Botter, Thomas Cerny, and Hompes, Daphne
- Subjects
Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14] ,Cancer Research ,All institutes and research themes of the Radboud University Medical Center ,Oncology ,Rare cancers Radboud Institute for Health Sciences [Radboudumc 9] - Abstract
Owing to the rarity and heterogeneity in biology and presentation, there are multiple areas in the diagnosis, treatment and follow-up of soft tissue sarcoma (STS), with no, low-level or conflicting evidence.During the first Consensus Conference on the State of Science in Sarcoma (CSSS), we used a modified Delphi process to identify areas of controversy in the field of sarcoma, to name topics with limited evidence-based data in which a scientific and knowledge gap may remain and a consensus statement will help to guide patient management. We determined scientific questions which need to be addressed in the future in order to generate evidence and to inform physicians and caregivers in daily clinical practice in order to improve the outcomes of patients with sarcoma. We conducted a vote on STS key questions and controversies prior to the CSSS meeting, which took place in May 2022.Sixty-two European sarcoma experts participated in the survey. Sixteen strong consensus (≥95%) items were identified by the experts, as well as 30 items with a ≥75% consensus on diagnostic and therapeutic questions. Ultimately, many controversy topics remained without consensus.In this manuscript, we summarise the voting results and the discussion during the CSSS meeting. Future scientific questions, priorities for clinical trials, registries, quality assurance, and action by stakeholders are proposed. Platforms and partnerships can support innovative approaches to improve management and clinical research in STS.
- Published
- 2023